Brevundimonas < Bromocriptine < Bromocryptine

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000049 (2014)	Omar Ouachikh [France] ; Wisam Dieb [France] ; Franck Durif [France] ; Aziz Hafidi [France]	Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats
000266 (2011)	P. Cesaro [France]	Maladie de Parkinson : les enjeux du traitement : MALADIE DE PARKINSON : PEUT-ON EN MODIFIER LE COURS EVOLUTIF ?
000644 (2009)	Joëlle Micallef [France] ; Marc Rey [France] ; Alexandre Eusebio [France] ; Christine Audebert [France] ; Frank Rouby [France] ; Elisabeth Jouve [France] ; Sophie Tardieu [France] ; Oliver Blin [France]	Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects
000752 (2008)	Sarah Vautier [France] ; Aline Milane [France] ; Christine Fernandez [France] ; Marion Buyse [France] ; Helene Chacun [France] ; Robert Farinotti [France]	Interactions between antiparkinsonian drugs and ABCB1/P-glycoprotein at the blood-brain barrier in a rat brain endothelial cell model
000777 (2008)	A. Marighetto [France] ; S. Valerio [France] ; J. N. Philippin [France] ; V. Bertaina-Anglade [France] ; C. Drieu La Rochelle [France] ; R. Jaffard [France] ; P. Morain [France]	Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents
000968 (2006)	Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]	The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease
000978 (2006)	Stéphane Thobois [France]	Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease : A review of the literature
000B73 (2004)	V. Ciubotaru [France] ; Y. Poinsignon [France] ; F. Brunet-Bourgin [France] ; M. Mestassi [France] ; D. Rosenbaum [France]	Pleuropéricardite sévère associée à un traitement par bromocriptine au long cours, revue de la littérature à propos d'un cas
000C99 (2003)	E. Polard [France] ; E. Trioux [France] ; L. Flet [France] ; F. Colin [France] ; H. Allain [France]	Ludopathie induite par la lévodopa associée à la bromocriptine
000D22 (2003)	J.-L. Montastruc [France] ; L. Schmitt [France] ; H. Bagheri [France]	Comportement pathologique de jeu au cours d'une maladie de Parkinson traitée par lévodopa et bromocriptine
000F34 (2002)	A. Angles [France] ; H. Bagheri [France] ; S. Saivin [France] ; J. L. Montastruc [France]	Interaction between lansoprazole and bromocriptine in a patient with Parkinson's disease
000F63 (2002)	C. Lebrun-Frenay [France] ; M. Borg [France]	Choosing the right dopamine agonist for patients with Parkinson's disease
000F90 (2001)		Intérêt thérapeutique du pergolide par rapport à la bromocriptine chez les parkinsoniens traités par L-dopa : revue des principaux essais cliniques publiés
000F97 (2001)	A. N. Lieberman ; A. Neophytides ; M. Leibowitz	Substitution entre pergolide et bromocriptine chez les parkinsoniens sous L-dopa
001020 (2001)		Comparaison directe de l'efficacité et de la tolérance du pergolide et de la bromocriptine en association à la L-dopa chez les parkinsoniens fluctuants
001030 (2001)	Jean-Louis Montastruc [France] ; Christine Brefel-Courbon [France] ; Jean-Michel Senard [France] ; Haleh Bagheri [France] ; Joaquim Ferreira [France] ; Olivier Rascol [France] ; Maryse Lapeyre-Mestre [France]	Sleep attacks and antiparkinsonian drugs : A pilot prospective pharmacoepidemiologic study
001048 (2001)	Jean-Louis Montastruc [France] ; Karine Desboeuf [France] ; Maryse Lapeyre-Mestre [France] ; Jean-Michel Senard [France] ; Olivier Rascol [France] ; Christine Brefel-Courbon [France]	Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease
001143 (2000)	O. Rascol [France] ; J.-L. Montastruc [France]	La place des agonistes dopaminergiques
001181 (2000)	J. J. Ferreira [France, Portugal] ; M. Galitzky [France] ; J. L. Montastruc [France] ; O. Rascol [France]	Sleep attacks and Parkinson's disease treatment
001342 (1999)		Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated Parkinsonian patients
001355 (1999)	S. Champagne [France] ; E. Coste [France] ; H. Peyriere [France] ; J. Nigond [France] ; E. Mania [France] ; M. Pons [France] ; D. Hillaire-Buys [France] ; P. Balmes [France] ; J.-P. Blayac [France] ; J.-M. Davy [France]	Chronic constrictive pericarditis induced by long-term bromocriptine therapy : Report of two cases

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i -k "Bromocriptine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/KwdEn.i  \
                -Sk "Bromocriptine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Bromocriptine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024